CF3 Derivatives of the Anticancer Ru(III) Complexes KP1019, NKP-1339, and Their Imidazole and Pyridine Analogues Show Enhanced Lipophilicity, Albumin Interactions, and Cytotoxicity (Q38773341)
Jump to navigation
Jump to search
scientific article published on 4 May 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CF3 Derivatives of the Anticancer Ru(III) Complexes KP1019, NKP-1339, and Their Imidazole and Pyridine Analogues Show Enhanced Lipophilicity, Albumin Interactions, and Cytotoxicity |
scientific article published on 4 May 2016 |
Statements
1 reference
CF3 Derivatives of the Anticancer Ru(III) Complexes KP1019, NKP-1339, and Their Imidazole and Pyridine Analogues Show Enhanced Lipophilicity, Albumin Interactions, and Cytotoxicity (English)
1 reference
Stephanie W Chang
1 reference
Andrew R Lewis
1 reference
Kathleen E Prosser
1 reference
John R Thompson
1 reference
Margarita Gladkikh
1 reference
Marcel B Bally
1 reference
Jeffrey J Warren
1 reference
Charles J Walsby
1 reference
4 May 2016
1 reference
1 reference
Identifiers
1 reference